Embecta Corp. (EMBC)
NASDAQ: EMBC · IEX Real-Time Price · USD
15.20
+2.03 (15.41%)
Jul 22, 2024, 11:31 AM EDT - Market open
Embecta Employees
Embecta had 2,200 employees as of September 30, 2023. The number of employees increased by 300 or 15.79% compared to the previous year.
Employees
2,200
Change (1Y)
300
Growth (1Y)
15.79%
Revenue / Employee
$514,773
Profits / Employee
$31,909
Market Cap
889.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2023 | 2,200 | 300 | 15.79% |
| Sep 30, 2022 | 1,900 | -129 | -6.36% |
| Sep 30, 2021 | 2,029 | -298 | -12.81% |
| Sep 30, 2020 | 2,327 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Phibro Animal Health | 1,920 |
| Travere Therapeutics | 380 |
| Evolus | 273 |
| OrthoPediatrics | 247 |
| Simulations Plus | 197 |
| Pliant Therapeutics | 158 |
| 4D Molecular Therapeutics | 147 |
| Abivax | 61 |
EMBC News
- 3 days ago - embecta to Report Fiscal Third Quarter 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir - GlobeNewsWire
- 4 weeks ago - Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors - PRNewsWire
- 2 months ago - Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results - GlobeNewsWire
- 2 months ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 2 months ago - embecta to Participate in Investor Events - GlobeNewsWire
- 3 months ago - embecta to Report Fiscal Second Quarter 2024 Financial Results - GlobeNewsWire
- 4 months ago - embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes - GlobeNewsWire